SPHS
Sophiris Bio, Inc. Common Stock
stockOTC
InactiveNov 5, 2021
0.0001USD0.000%(0.00)78,055
Loading…
Loading…
SPHS Profile
Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in research and development of products for the treatment of urological diseases. It is developing topsalysin (PRX302) for treatment of benign prostatic hyperplasia.
SPHS Performance
| Period | Price | Date | Change |
|---|